Hogy Medical Co.,Ltd. (HGYMF)
USD 24.34
(0.0%)
USD 24.34
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 12.49 Billion JPY | 11415.4% |
| 2023 | 113.43 Million JPY | -5.5% |
| 2022 | 120.03 Million JPY | -8.02% |
| 2021 | 130.5 Million JPY | -1.92% |
| 2020 | 133.05 Million JPY | 6.5% |
| 2019 | 124.94 Million JPY | -1.97% |
| 2018 | 127.44 Million JPY | -8.36% |
| 2017 | 139.07 Million JPY | -5.49% |
| 2016 | 147.15 Million JPY | -99.15% |
| 2015 | 17.37 Billion JPY | -2.08% |
| 2014 | 17.74 Billion JPY | 6.18% |
| 2013 | 16.71 Billion JPY | 3.42% |
| 2012 | 16.16 Billion JPY | -1.94% |
| 2011 | 16.48 Billion JPY | 1.77% |
| 2010 | 16.19 Billion JPY | 4.25% |
| 2009 | 15.53 Billion JPY | 4.14% |
| 2008 | 14.91 Billion JPY | 8.07% |
| 2007 | 13.8 Billion JPY | 1.69% |
| 2006 | 13.57 Billion JPY | 6.59% |
| 2005 | 12.73 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q4 | 2.73 Billion JPY | 11264.82% |
| 2024 FY | 12.49 Billion JPY | 10911.16% |
| 2024 Q1 | 24.91 Million JPY | -11.6% |
| 2024 Q2 | 22.37 Million JPY | -10.2% |
| 2024 Q3 | 24.03 Million JPY | 7.45% |
| 2023 Q4 | 28.18 Million JPY | -13.6% |
| 2023 Q1 | 30.11 Million JPY | 0.75% |
| 2023 FY | 113.43 Million JPY | -5.5% |
| 2023 Q3 | 32.61 Million JPY | 30.16% |
| 2023 Q2 | 25.05 Million JPY | -16.8% |
| 2022 Q4 | 29.89 Million JPY | -17.94% |
| 2022 Q3 | 36.42 Million JPY | 6.6% |
| 2022 FY | 120.03 Million JPY | -8.02% |
| 2022 Q1 | 34.05 Million JPY | -99.08% |
| 2022 Q2 | 34.17 Million JPY | 0.35% |
| 2021 Q2 | 3.85 Billion JPY | 10.17% |
| 2021 Q1 | 3.5 Billion JPY | -7.94% |
| 2021 Q3 | 4.26 Billion JPY | 10.58% |
| 2021 FY | 130.5 Million JPY | -1.92% |
| 2021 Q4 | 3.7 Billion JPY | -13.24% |
| 2020 Q3 | 4.06 Billion JPY | 7.55% |
| 2020 FY | 133.05 Million JPY | 6.5% |
| 2020 Q1 | 3.79 Billion JPY | 16.7% |
| 2020 Q4 | 3.8 Billion JPY | -6.31% |
| 2020 Q2 | 3.77 Billion JPY | -0.53% |
| 2019 FY | 124.94 Million JPY | -1.97% |
| 2019 Q1 | 3.73 Billion JPY | 7.67% |
| 2019 Q2 | 3.77 Billion JPY | 1.04% |
| 2019 Q3 | 4.07 Billion JPY | 7.9% |
| 2019 Q4 | 3.25 Billion JPY | -20.1% |
| 2018 Q4 | 3.46 Billion JPY | -7.47% |
| 2018 Q3 | 3.74 Billion JPY | 5.64% |
| 2018 Q2 | 3.54 Billion JPY | -4.32% |
| 2018 Q1 | 3.7 Billion JPY | -2.78% |
| 2018 FY | 127.44 Million JPY | -8.36% |
| 2017 FY | 139.07 Million JPY | -5.49% |
| 2017 Q2 | 4.22 Billion JPY | -0.61% |
| 2017 Q1 | 4.25 Billion JPY | -4.9% |
| 2017 Q3 | 4.21 Billion JPY | -0.17% |
| 2017 Q4 | 3.81 Billion JPY | -9.58% |
| 2016 Q2 | 4.39 Billion JPY | 2.66% |
| 2016 FY | 147.15 Million JPY | -99.15% |
| 2016 Q3 | 4.44 Billion JPY | 1.21% |
| 2016 Q4 | 4.46 Billion JPY | 0.54% |
| 2016 Q1 | 4.27 Billion JPY | 1.37% |
| 2015 Q2 | 4.31 Billion JPY | 2.28% |
| 2015 Q1 | 4.21 Billion JPY | 0.6% |
| 2015 Q3 | 4.62 Billion JPY | 7.16% |
| 2015 FY | 17.37 Billion JPY | -2.08% |
| 2015 Q4 | 4.22 Billion JPY | -8.74% |
| 2014 Q4 | 4.19 Billion JPY | -14.09% |
| 2014 FY | 17.74 Billion JPY | 6.18% |
| 2014 Q3 | 4.88 Billion JPY | 10.4% |
| 2014 Q2 | 4.42 Billion JPY | 4.07% |
| 2014 Q1 | 4.24 Billion JPY | 11.0% |
| 2013 FY | 16.71 Billion JPY | 3.42% |
| 2013 Q3 | 4.62 Billion JPY | 11.2% |
| 2013 Q4 | 3.82 Billion JPY | -17.25% |
| 2013 Q1 | 4.1 Billion JPY | 7.27% |
| 2013 Q2 | 4.16 Billion JPY | 1.46% |
| 2012 Q3 | 4.25 Billion JPY | 9.11% |
| 2012 FY | 16.16 Billion JPY | -1.94% |
| 2012 Q1 | 4.19 Billion JPY | 8.79% |
| 2012 Q4 | 3.82 Billion JPY | -10.07% |
| 2012 Q2 | 3.89 Billion JPY | -7.15% |
| 2011 Q2 | 4.2 Billion JPY | 4.32% |
| 2011 Q3 | 4.39 Billion JPY | 4.71% |
| 2011 FY | 16.48 Billion JPY | 1.77% |
| 2011 Q1 | 4.02 Billion JPY | 5.72% |
| 2011 Q4 | 3.85 Billion JPY | -12.34% |
| 2010 Q1 | 4 Billion JPY | 8.36% |
| 2010 Q3 | 4.27 Billion JPY | 3.89% |
| 2010 Q2 | 4.11 Billion JPY | 2.85% |
| 2010 FY | 16.19 Billion JPY | 4.25% |
| 2010 Q4 | 3.8 Billion JPY | -10.88% |
| 2009 Q2 | 4 Billion JPY | 0.0% |
| 2009 FY | 15.53 Billion JPY | 4.14% |
| 2009 Q3 | 4.01 Billion JPY | 0.12% |
| 2009 Q4 | 3.69 Billion JPY | -7.94% |
| 2008 FY | 14.91 Billion JPY | 8.07% |
| 2007 FY | 13.8 Billion JPY | 1.69% |
| 2006 FY | 13.57 Billion JPY | 6.59% |
| 2005 FY | 12.73 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.69 Million USD | -735050.876% |
| Ansell Limited | 624.8 Million USD | -1899.2% |
| Ansell Limited | 624.8 Million USD | -1899.2% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 113.94 Million USD | -10862.597% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -9248724.553% |
| Psykey, Inc. | 415.97 Thousand USD | -3002717.47% |
| ConvaTec Group Plc | 1.2 Billion USD | -938.231% |
| ConvaTec Group Plc | 1.17 Billion USD | -963.245% |
| Encision Inc. | 3.13 Million USD | -398214.775% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 794.01 Thousand USD | -1573048.047% |
| LifePoint, Inc. | -71.35 Thousand USD | 17504794.638% |
| Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 9535214.504% |
| Paradigm Medical Industries, Inc. | 525 Thousand USD | -2379138.095% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 603.24 Thousand USD | -2070551.814% |
| Reflect Scientific, Inc. | 596.42 Thousand USD | -2094225.988% |
| SmileDirectClub, Inc. | 275.84 Million USD | -4428.235% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | -1286.766% |
| SheerVision, Inc. | 2.17 Million USD | -573958.934% |
| United Health Products, Inc. | -4857.00 USD | 257175311.036% |
| Vasamed, Inc. | -69.38 Thousand USD | 18001771.759% |
| Wearable Health Solutions, Inc. | 267.66 Thousand USD | -4666589.083% |
| Yubo International Biotech Limited | 52.65 Thousand USD | -23723595.206% |